Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
To use prospectively registered data from the Danish nationwide rheumatological database (DANBIO) to describe disease activity, clinical response, treatment duration and predictors of drug survival (ie, number of days individual patients maintained treatment) and clinical response among patients with ankylosing spondylitis (AS) receiving their first treatment series with a tumour necrosis factor a (TNFa) inhibitor.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Annals of the Rheumatic Diseases |
Vol/bind | 69 |
Udgave nummer | 11 |
Sider (fra-til) | 2002-8 |
Antal sider | 7 |
ISSN | 0003-4967 |
DOI | |
Status | Udgivet - 1 nov. 2010 |
ID: 34064408